Trump to Review Childhood Vaccination Guidelines
President Donald Trump plans to instruct key health officials to evaluate childhood immunization schedules systematically. This review will involve considering vaccination practices in other wealthy nations, with the potential for updating U.S. recommendations if these foreign approaches seem more effective, as noted in a memo acquired by the Daily Caller News Foundation.
According to the memo, “As of January 2025, the United States suggests vaccinations for children against 18 diseases, which is higher than what other countries recommend.” It further states that “research is warranted to ensure that Americans have access to the best medical advice available globally.”
Trump has tasked the Secretary of Health and Human Services and the Director of the Centers for Disease Control and Prevention with incorporating best practices from other nations when they are medically sound. The memo notes a disparity: the U.S. recommends vaccinations for 18 diseases, while Denmark only recommends 10, Japan suggests 14, and Germany has 15.
Health Secretary Robert F. Kennedy Jr. has been vocal in his criticism of the current U.S. childhood immunization schedule.
Moreover, the Trump administration has retracted its blanket recommendation that all children receive an annual COVID-19 vaccine booster indefinitely. FDA Commissioner Marty McCulley and Chief Medical Officer Vinay Prasad indicated that new coronavirus booster shots for children and healthy non-elderly individuals will not be approved unless clinical trials show their efficacy. Recently, Prasad revealed that an investigation uncovered 10 children who died as a result of coronavirus vaccines, leading to revised vaccine regulations and calls for “introspection.”
Trump’s memo comes after a two-day meeting with CDC vaccine advisers, during which they revised the U.S. hepatitis B vaccination policy to align with that of 24 other nations.
The meeting included a presentation by Tracy Beth Hegg, director of the FDA’s Center for Drug Evaluation and Research, highlighting the discrepancies between the U.S. childhood vaccination schedule and those of other developed countries. Hegg raised a pertinent question: “Why are we so different from other developed countries? And is it ethically and scientifically justified?” She emphasized the obligation to base recommendations on scientific evidence for the benefit of U.S. children.
